跳到正文
原文
Endpoints News 生物医药· ENDPOINTS·· 2026-10-02AI 评分24

Summit Therapeutics 与 AstraZeneca、Daiichi 达成合作;Eccogene 获 5000 万美元里程碑付款

Summit partners with AstraZeneca and Daiichi; Eccogene earns $50M milestone

AI 导读

Summit Therapeutics 与 AstraZeneca 及 Daiichi 达成合作,将联合测试其癌症药物 Datroway。Eccogene 获得 5000 万美元里程碑付款。此外还有 Regeneron 的相关消息。

正文

Plus news about Re­gen­eron.

Sum­mit Ther­a­peu­tics to test can­cer drug with Da­troway: The biotech agreed to part­ner with As­traZeneca and Dai­ichi …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

来源:Endpoints News 生物医药 · endpoints.news